The RADAR-CNS (Remote assessment of disease and relapse – Central Nervous System) programme aims to improve patients’ quality of life, and potentially to change how these and other chronic disorders are treated.

Continuous remote assessment using smartphones and wearable devices provides a complete picture of a patient’s condition at a level of detail which was previously unachievable. Moreover, it could potentially allow treatment to begin before a patient’s health deteriorates, preventing the patient relapsing or becoming more ill before they seek treatment.

RADAR-CNS is jointly led by King’s College London (Matthew Hotopf) and Janssen Pharmaceutica NV (Vaibhav Narayan), funded by the Innovative Medicines Initiative (a Public Private Partnership established between the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European Union) and includes 24 organisations from across Europe and the US. The programme brings together experts from diverse fields including clinical research, engineering, computer science, information technology, data analytics and health services.

Epilepsy, depression, and multiple sclerosis are distinct disorders, with different causes and symptoms, all of which can be severely detrimental to patients’ quality of life and life expectancy. For all three disorders, patients often experience periods where their symptoms are manageable, followed by periods of deterioration and acute illness (relapse). Patient surveys have repeatedly highlighted the need to predict when relapses will happen and to improve the treatments which are available to stop them from occurring.

Patients will be involved in RADAR-CNS from the start, helping to identify the most important symptoms to target. They will also advise researchers on how best to implement remote measurement technologies in a way that is acceptable and engaging to patients, including accounting for privacy and security.

Press release including MindTech's role through University of Nottingham partner: http://mindtech.org.uk/news/128-remote-assessment-of-disease-and-relapse-in-central-nervous-system-disorders-a-major-european-research-programme-is-launched.html

More information: http://www.radar-cns.org/

Contact: Dr. Michael Craven

Join MindTech (click)

We would love to keep in touch with you regarding our work and how you might be able to help. Please fill in this form so we can contact you.

Have you had your say yet? Tell us your top 3 research questions about digital for mental health… https://t.co/5IVZ929SuE

What if tech tried to be healing instead of just addictive? Interesting article about designing wellbeing into tech https://t.co/yOlYVF6f2v